CJC-1295 (No DAC) + Ipamorelin (50/50 Blend) – Research Grade Peptides

Lyophilised Powder | ≥99% Purity

CJC-1295 (No DAC) + Ipamorelin Blend (50/50 Blend) is a synthetically manufactured research peptide blend supplied as a high-purity lyophilised powder. It is characterised as a combined formulation of a growth hormone–releasing hormone (GHRH) analogue (CJC-1295 No DAC / Modified GRF (1-29)) and a growth hormone secretagogue receptor (GHSR) agonist analogue (Ipamorelin), and is supplied strictly for laboratory and analytical research applications.

Research Context

CJC-1295 (No DAC) + Ipamorelin is currently studied in laboratory environments for its interaction with multiple endocrine signalling pathways involved in growth hormone regulation. This blended formulation is commonly investigated in research settings where combined peptide activity is being studied across complementary mechanisms of growth hormone axis stimulation.

In experimental models, peptides within these classes are studied for their interaction with:

• Growth hormone–releasing hormone (GHRH) receptor signalling pathways
• Growth hormone secretagogue receptor (GHSR-1a) signalling pathways
• Endocrine feedback mechanisms involving growth hormone (GH) and insulin-like growth factor-1 (IGF-1)

In laboratory research settings, CJC-1295 (No DAC) (Modified GRF (1-29)) has been examined for its potential involvement in GHRH-mediated growth hormone secretion signalling and pulsatile GH dynamics. Ipamorelin has been examined for its potential involvement in ghrelin-mimetic signalling at GHSR pathways associated with GH release mechanisms.

Research interest in this blend primarily focuses on understanding:

• GHRH receptor and GHSR pathway pharmacology
• Regulation of growth hormone (GH) secretion dynamics and pulsatility
• Endocrine feedback mechanisms involving IGF-1 signalling
• Multi-pathway stimulation models within GH axis research

Any reference to receptor activity or biological mechanisms is provided strictly for scientific context within research settings.

Technical Specifications

Storage & Handling

• Store lyophilised peptide at2–8°C for short-term storage.
• For extended storage, keep at−20°C or below.
• Protect fromlight and moisture.
• Avoidrepeated freeze–thaw cyclesafter reconstitution.
• Use appropriatelaboratory handling procedures.
• Proper storage and handling are essential to maintain peptide integrity and stability for research applications.

Intended Use

This product is supplied strictly for laboratory and scientific research purposes only.

It is:

• Not for human consumption
• Not for animal or veterinary use
• Not a therapeutic good
• Not approved for medical, diagnostic, or clinical applications

Any reference to biological mechanisms or receptor activity is provided solely for scientific context.

Purchasers are responsible for ensuring compliance with all applicable laws and proper laboratory protocols.